DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Bruix J, Takayama T, Mazzaferro V et al.
STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC).
J Clin Oncol 2014;
32: 5s
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.